Harvard’s CircaVent identifies drugs for bipolar disorder
Harvard University’s Wyss Institute has launched CircaVent, a high-throughput drug screening platform aimed at treating bipolar disorder (BD). This innovative…
Harvard University’s Wyss Institute has launched CircaVent, a high-throughput drug screening platform aimed at treating bipolar disorder (BD). This innovative…
French 
English 
German 
Russian 
Spanish 
Belarusian 
Ukrainian